Clinical Trials in San Diego

Showing 4581-4600 of 14,679 trials

ACP-104 in Acutely Psychotic Subjects With Schizophrenia

NCT00490516

This is a randomized, double-blind, placebo-controlled parallel-group, 6-week study, evaluating two dose levels of ACP-104 or Placebo twice a day in patients with schizophrenia who are experiencing an acute psychotic episode.

Schizophrenia

ACADIA Pharmaceuticals Inc.247 participantsStarted Jun 2007

Anaheim, California, United States • Costa Mesa, California, United States • Covina, California, United States +18 more locations

Approved For Marketing< 1 mile

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

NCT03906331

Expanded access for participants with cancer with RET activation who are ineligible for an ongoing selpercatinib (also known as LOXO-292) clinical trial or have other considerations that prevent access to selpercatinib through an existing clinical trial. The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the expanded access program.

Non Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+4 more

Eli Lilly and Company

Goodyear, Arizona, United States • Scottsdale, Arizona, United States • Duarte, California, United States +61 more locations

ACP-104 in Acutely Psychotic Subjects With Schizophrenia

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

Find Trials by Condition in San Diego

Communities Fighting COVID Return to School

to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction

The Healthy Elderly Longevity Cohort

The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

CLUSTER Trial for Outbreak Detection and Response

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Intermediate-Size Expanded Access Protocol (EAP) for LP352

Novel Experimental COVID-19 Therapies Affecting Host Response

Heart EXPAND Continued Access Protocol

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Non-Complex Biliary Stones DSC vs ERC

A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)